Howard Burnett is Vice-President, and Head of Global Pulmonary Category for Aptar Pharma. He has more than 30 years of experience in the field of inhalation devices for treatment of respiratory conditions. Mr Burnett has a background in mechanical engineering, having studied particle physics as part of his bachelor’s degree from the University of York (UK). His postgraduate qualifications include management studies and education. He has held management positions in R&D, engineering, operations, marketing and business development.

More contributions